IMARC Group, a leading market research company, has recently releases report titled “Interventional Cardiology and Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033,” The study provides a detailed analysis of the industry, including the global interventional cardiology and peripheral vascular devices market trends, size, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the interventional cardiology and peripheral vascular devices market?

The global interventional cardiology and peripheral vascular devices market size reached USD 26.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033.

Factors Affecting the Growth of the Interventional Cardiology And Peripheral Vascular Devices Industry:

Rising Prevalence of Cardiovascular Diseases and Peripheral Vascular Disorders

The increasing prevalence of cardiovascular diseases (CVDs) and peripheral vascular disorders (PVDs) is a primary driver of growth in the interventional cardiology and peripheral vascular devices market. CVDs, including conditions such as coronary artery disease, heart failure, and arrhythmias, are among the leading causes of morbidity and mortality worldwide. Factors such as aging populations, high rates of hypertension, diabetes, and obesity, and sedentary lifestyles contribute significantly to this rise. As the global population ages, the incidence of these conditions increases, leading to a higher demand for medical interventions. Peripheral vascular disorders, which involve diseases of the blood vessels outside the heart and brain, such as peripheral artery disease (PAD), are also becoming more common. This growing burden on healthcare systems drives the need for advanced diagnostic and therapeutic devices to manage and treat these conditions effectively. 

Technological Innovations in Minimally Invasive Procedures

Technological advancements in minimally invasive procedures have significantly impacted the interventional cardiology and peripheral vascular devices market. These innovations include the development of sophisticated imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), which provide high-resolution images of blood vessels, allowing for more precise diagnostics and treatments. Additionally, the advent of advanced catheter-based techniques and devices, such as drug-eluting stents and balloon angioplasty systems, has revolutionized treatment options by offering less invasive alternatives to traditional surgical procedures. These technologies not only enhance the accuracy and effectiveness of interventions but also reduce patient recovery times, minimize procedural risks, and improve overall outcomes. The continuous evolution of these technologies is driven by ongoing research and development efforts aimed at addressing unmet clinical needs and improving patient experiences. 

Increasing Adoption of Advanced Devices by Healthcare Facilities

The rising adoption of advanced interventional cardiology and peripheral vascular devices by healthcare facilities is a significant factor driving market growth. As medical facilities increasingly recognize the benefits of state-of-the-art devices, they are incorporating these technologies into their practice to improve patient care and outcomes. Advanced devices, such as drug-eluting stents, bioresorbable scaffolds, and cutting-edge imaging systems, offer enhanced diagnostic and therapeutic capabilities compared to traditional options. Healthcare facilities are investing in these technologies to stay competitive and provide the highest standard of care. The adoption is also fueled by the growing availability of these devices through various distribution channels and the increased focus on evidence-based medicine, which emphasizes the use of proven, high-quality devices.

Request for a sample copy of this report: https://www.imarcgroup.com/interventional-cardiology-peripheral-vascular-devices-market/requestsample

Interventional Cardiology And Peripheral Vascular Devices Market Report Segmentation:

Breakup By Product Type:

• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Accessories
• Angioplasty Balloons
• Angioplasty Stents
• Angioplasty Catheters
• Endovascular Aneurysm Repair Stent Grafts

Angioplasty balloons are the largest segment due to their critical role in treating coronary artery disease by dilating narrowed blood vessels and their widespread use in both elective and emergency procedures.

Breakup By Indication:

• Coronary Intervention
• Peripheral Arterial Disease

By the indication, the market is divided into coronary intervention and peripheral arterial disease.

Breakup By Age Group:

• Geriatric
• Adults
• Paediatric

The geriatric age group represents the largest segment because older individuals are more prone to cardiovascular and peripheral vascular diseases, necessitating frequent interventional procedures.

Breakup By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Hospitals are the largest segment as they are the primary settings for complex interventional procedures, including those involving cardiology and peripheral vascular devices, due to their comprehensive facilities and specialized care teams.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America was the largest market due to its advanced healthcare infrastructure, high prevalence of cardiovascular conditions, and significant investments in medical technology and research.

Global Interventional Cardiology And Peripheral Vascular Devices Market Trends:

The global interventional cardiology and peripheral vascular devices market is driven by a confluence of factors that are propelling its growth, such as the rising prevalence of cardiovascular diseases and peripheral vascular disorders is significantly boosting demand for advanced medical interventions and devices. In line with this, technological innovations, such as the development of minimally invasive procedures and cutting-edge imaging technologies, are enhancing treatment efficacy and patient outcomes. Furthermore, the increasing adoption of these advanced devices by healthcare facilities globally is fostering market expansion. Additionally, a growing geriatric population, more susceptible to cardiovascular issues, is also contributing to market growth. Apart from this, improved healthcare infrastructure and increased healthcare expenditure in emerging economies are opening new opportunities for market players.

Top Interventional Cardiology And Peripheral Vascular Devices Market Leaders:

The interventional cardiology and peripheral vascular devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

• Abbott Laboratories
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Group Incorporated
• Cordis Corporation
• Koninklijke Philips N.V.
• Medtronic plc.
• Teleflex Incorporated
• Terumo Corporation

Ask Analyst Browse full report with TOC List of Figures: https://www.imarcgroup.com/request?type=report&id=7542&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145